BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2841999)

  • 1. Anticonvulsant effects of phencyclidine-like drugs: relation to N-methyl-D-aspartic acid antagonism.
    Leander JD; Rathbun RC; Zimmerman DM
    Brain Res; 1988 Jun; 454(1-2):368-72. PubMed ID: 2841999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the anticonvulsant effects of competitive and non-competitive antagonists of the N-methyl-D-aspartate receptor.
    Nevins ME; Arnolde SM
    Brain Res; 1989 Nov; 503(1):1-4. PubMed ID: 2558775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
    Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD
    Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticonvulsant effects of antagonists of the N-methyl-D-aspartate receptor complex in a genetic model of epilepsy: the quaking mouse.
    Mitrovic N; Besson MJ; Maurin Y
    Eur J Pharmacol; 1990 Feb; 176(3):357-61. PubMed ID: 2158455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock models.
    McNamara JO; Russell RD; Rigsbee L; Bonhaus DW
    Neuropharmacology; 1988 Jun; 27(6):563-8. PubMed ID: 2843782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between GABAergic anticonvulsants and the NMDA receptor antagonist MK 801 against MES- and picrotoxin-induced convulsions in rats.
    Kulkarni SK; Ticku MK
    Life Sci; 1989; 44(18):1317-23. PubMed ID: 2541293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the NMDA receptor antagonist MK-801 against amygdaloid-kindled seizures in the rat.
    Young NA; Lewis SJ; Vajda FJ; Beart PM
    Exp Neurol; 1989 Feb; 103(2):199-202. PubMed ID: 2536332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo labelling of the NMDA receptor channel complex by [3H]MK-801.
    Price GW; Ahier RG; Middlemiss DN; Singh L; Tricklebank MD; Wong EH
    Eur J Pharmacol; 1988 Dec; 158(3):279-82. PubMed ID: 2472964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel anticonvulsant MK-801: a potent and specific ligand of the brain phencyclidine/sigma-receptor.
    Sircar R; Rappaport M; Nichtenhauser R; Zukin SR
    Brain Res; 1987 Dec; 435(1-2):235-40. PubMed ID: 2827853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures.
    Gilbert ME
    Brain Res; 1988 Oct; 463(1):90-9. PubMed ID: 2848609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the discriminative stimulus produced by phencyclidine due to an interaction with N-methyl-D-aspartate receptors?
    Jackson A; Sanger DJ
    Psychopharmacology (Berl); 1988; 96(1):87-92. PubMed ID: 2906445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phencyclidine and related compounds evoked [3H]dopamine release from rat mesencephalic cell cultures by a mechanism independent of the phencyclidine receptor, sigma binding site, or dopamine uptake site.
    Mount H; Boksa P; Chaudieu I; Quirion R
    Can J Physiol Pharmacol; 1990 Sep; 68(9):1200-6. PubMed ID: 1980428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of phencyclidine (PCP)-n-methyl-d-aspartate (NMDA) receptor interaction: implications for drug abuse research.
    Zukin SR; Javitt DC
    NIDA Res Monogr; 1989; 95():247-54. PubMed ID: 2561829
    [No Abstract]   [Full Text] [Related]  

  • 14. The psychotomimetic drug phencyclidine labels two high affinity binding sites in guinea pig brain: evidence for N-methyl-D-aspartate-coupled and dopamine reuptake carrier-associated phencyclidine binding sites.
    Rothman RB; Reid AA; Monn JA; Jacobson AE; Rice KC
    Mol Pharmacol; 1989 Dec; 36(6):887-96. PubMed ID: 2557536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel anticonvulsant MK-801 interacts with central phencyclidine recognition sites in rat brain.
    Loo PA; Braunwalder AF; Williams M; Sills MA
    Eur J Pharmacol; 1987 Mar; 135(2):261-3. PubMed ID: 3034630
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat.
    Marrannes R; Willems R; De Prins E; Wauquier A
    Brain Res; 1988 Aug; 457(2):226-40. PubMed ID: 2851364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of dextromethorphan and carbetapentane as anticonvulsants and N-methyl-D-aspartic acid antagonists in mice.
    Leander JD
    Epilepsy Res; 1989; 4(1):28-33. PubMed ID: 2666123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and conformational aspects of the binding of aryl-alkyl amines to the phencyclidine binding site.
    Thurkauf A; Monn J; Mattson MV; Jacobson AE; Rice KC
    NIDA Res Monogr; 1989; 95():51-6. PubMed ID: 2561843
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy.
    Sato K; Morimoto K; Okamoto M
    Brain Res; 1988 Oct; 463(1):12-20. PubMed ID: 2848606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amnesic effect of the novel anticonvulsant MK-801.
    Benvenga MJ; Spaulding TC
    Pharmacol Biochem Behav; 1988 May; 30(1):205-7. PubMed ID: 3051045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.